ZEB2 and prostate carcinoma: Moreover, miR-200c-3p was found to remarkably inhibit the formation of migration and invasion in prostate cancer cells via suppression of E-cadherin-induced Epithelial-mesenchymal transition (EMT), achieved by targeting ZEB2 (Zhang et al. 2019).